Dimerization	O
of	O
NF-KB2	B-protein
with	O
RelA	B-protein
(	I-protein
p65	I-protein
)	I-protein
regulates	O
DNA	O
binding	O
,	O
transcriptional	O
activation	O
,	O
and	O
inhibition	O
by	O
an	O
I	B-protein
kappa	I-protein
B-alpha	I-protein
(	O
MAD-3	B-protein
)	O
.	O

Inducible	O
expression	O
of	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
is	O
regulated	O
by	O
a	O
cellular	O
transcription	B-protein
factor	I-protein
,	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
(	O
NF-kappa	B-protein
B	I-protein
)	O
.	O

NF-kappa	B-protein
B	I-protein
is	O
composed	O
of	O
distinct	O
subunits	O
;	O
five	O
independent	O
genes	O
,	O
NFKB1	B-DNA
(	O
p105	B-protein
)	O
,	O
NFKB2	B-DNA
(	O
p100	B-protein
)	O
,	O
RelA	B-protein
(	I-protein
p65	I-protein
)	I-protein
,	O
c-rel	B-DNA
and	O
relB	B-DNA
,	O
that	O
encode	O
related	O
proteins	O
that	O
bind	O
to	O
kappa	B-DNA
B	I-DNA
DNA	I-DNA
elements	I-DNA
have	O
been	O
isolated	O
.	O

We	O
have	O
previously	O
found	O
that	O
NFKB2	B-protein
(	I-protein
p49/p52	I-protein
)	I-protein
acts	O
in	O
concert	O
with	O
RelA	B-protein
(	I-protein
p65	I-protein
)	I-protein
to	O
stimulate	O
the	O
HIV	B-DNA
enhancer	I-DNA
in	O
Jurkat	O
T-leukemia	B-cell_line
cells	I-cell_line
.	O

Here	O
we	O
examine	O
the	O
biochemical	O
basis	O
for	O
the	O
transcriptional	O
regulation	O
of	O
HIV	O
by	O
NFKB2	B-protein
.	O

Using	O
Scatchard	O
analysis	O
,	O
we	O
have	O
determined	O
the	O
dissociation	O
constants	O
of	O
homodimeric	B-protein
p49	I-protein
and	O
heterodimeric	B-protein
p49/p65	I-protein
for	O
binding	O
to	O
the	O
HIV	B-DNA
kappa	I-DNA
B	I-DNA
site	I-DNA
.	O

p49	B-protein
has	O
a	O
approximately	O
18-fold-lower	O
affinity	O
for	O
the	O
HIV	O
kappa	B-DNA
B	I-DNA
site	I-DNA
(	O
KD	O
=	O
69.1	O
pM	O
)	O
than	O
does	O
the	O
approximately	O
50-kDa	O
protein	O
NFKB1	B-protein
(	I-protein
p50	I-protein
)	I-protein
derived	O
from	O
p105	B-protein
(	O
KD	O
=	O
3.9	O
pM	O
)	O
.	O

In	O
contrast	O
,	O
the	O
affinity	O
of	O
heterodimeric	B-protein
NFKB2	I-protein
(	I-protein
p49	I-protein
)	I-protein
/RelA	I-protein
(	I-protein
p65	I-protein
)	I-protein
for	O
this	O
site	O
is	O
approximately	O
6-fold	O
higher	O
(	O
KD	O
=	O
11.8	O
pM	O
)	O
than	O
that	O
of	O
p49	B-protein
alone	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
in	O
vitro	O
transcription	O
was	O
stimulated	O
18-fold	O
by	O
the	O
addition	O
of	O
preformed	O
,	O
heterodimeric	B-protein
NFKB2	I-protein
(	I-protein
p49	I-protein
)	I-protein
/RelA	I-protein
(	I-protein
p65	I-protein
)	I-protein
protein	I-protein
.	O

Transcriptional	O
activation	O
of	O
the	O
HIV	O
enhancer	O
was	O
also	O
subject	O
to	O
regulation	O
by	O
recently	O
cloned	O
I	B-protein
kappa	I-protein
B-alpha	I-protein
(	O
MAD-3	B-protein
)	O
.	O

Recombinant	O
I	O
kappa	O
B-alpha	O
(	O
MAD-3	B-protein
)	O
inhibited	O
the	O
DNA	O
binding	O
activity	O
of	O
p65	B-protein
,	O
p49/p65	B-protein
,	O
and	O
p50/p65	B-protein
but	O
stimulated	O
the	O
binding	O
of	O
NFKB2	B-protein
(	O
p49	B-protein
)	O
or	O
NFKB1	O
(	O
p50	O
)	O
.	O

Functional	O
activation	O
of	O
an	O
HIV	O
reporter	O
plasmid	O
by	O
p49/p65	B-protein
in	O
transiently	B-cell_line
transfected	I-cell_line
Jurkat	I-cell_line
T-leukemia	I-cell_line
cells	I-cell_line
was	O
also	O
inhibited	O
by	O
coexpression	O
of	O
MAD-3	B-protein
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

MOLECULAR	NULL
aND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Feb.	NULL
1993	NULL
,	NULL
p.	NULL
1315-1322	NULL
0270-7306/93/031315-08	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Dimerization	NULL
of	NULL
NF-KB2	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
Regulates	NULL
DNA	NULL
Binding	NULL
,	NULL
Transcriptional	NULL
Activation	NULL
,	NULL
and	NULL
Inhibition	NULL
by	NULL
an	NULL
IKB-a	NULL
«	NULL
(	NULL
MAD-3	NULL
)	NULL
COLIN	NULL
S.	NULL
DUCKETT	NULL
,	NULL
'	NULL
NEIL	NULL
D.	NULL
PERKINS	NULL
,	NULL
TIMOTHY	NULL
F.	NULL
KOWALIK	NULL
,	NULL
``	NULL
ROLAND	NULL
M.	NULL
SCHMID	NULL
,	NULL
!	NULL

ENG-SHANG	NULL
HUANG	NULL
,	NULL
``	NULL
ALBERT	NULL
S.	NULL
BALDWIN	NULL
,	NULL
JR.	NULL
,	NULL
``	NULL
anp	NULL
GARY	NULL
J.	NULL
NABEL'*	NULL
Departments	NULL
of	NULL
Internal	NULL
Medicine	NULL
and	NULL
Biological	NULL
Chemistry	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Center	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
Michigan	NULL
48109-0650	NULL
,	NULL
>	NULL
and	NULL
Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
at	NULL
Chapel	NULL
Hill	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
North	NULL
Carolina	NULL
27599-7295	NULL
``	NULL
Received	NULL
12	NULL
August	NULL
1992/Returned	NULL
for	NULL
modification	NULL
5	NULL
October	NULL
1992/Accepted	NULL
18	NULL
November	NULL
1992	NULL
Inducible	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
cellular	NULL
transcription	NULL
factor	NULL
,	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
.	NULL

NF-KB	NULL
is	NULL
composed	NULL
of	NULL
distinct	NULL
subunits	NULL
;	NULL
five	NULL
independent	NULL
genes	NULL
,	NULL
NFKB1	NULL
(	NULL
p105	NULL
)	NULL
,	NULL
NFKB2	NULL
(	NULL
p100	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
c-rel	NULL
and	NULL
relB	NULL
,	NULL
that	NULL
encode	NULL
related	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
«	NULL
B	NULL
DNA	NULL
elements	NULL
have	NULL
been	NULL
isolated	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
found	NULL
that	NULL
NFKB2	NULL
(	NULL
p49/p52	NULL
)	NULL
acts	NULL
in	NULL
concert	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
to	NULL
stimulate	NULL
the	NULL
HIV	NULL
enhancer	NULL
in	NULL
Jurkat	NULL
T-leukemia	NULL
cells	NULL
.	NULL

Here	NULL
we	NULL
examine	NULL
the	NULL
biochemical	NULL
basis	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
HIV	NULL
by	NULL
NFKB2	NULL
.	NULL

Using	NULL
Scatchard	NULL
analysis	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
the	NULL
dissociation	NULL
constants	NULL
of	NULL
homodimeric	NULL
p49	NULL
and	NULL
heterodimeric	NULL
p49/p65	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
HIV	NULL
B	NULL
site	NULL
.	NULL

p49	NULL
has	NULL
a	NULL
~18-fold-lower	NULL
affinity	NULL
for	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
(	NULL
K	NULL
,	NULL
,	NULL
=	NULL
69.1	NULL
pM	NULL
)	NULL
than	NULL
does	NULL
the	NULL
~50-kDa	NULL
protein	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
derived	NULL
from	NULL
p105	NULL
(	NULL
K	NULL
,	NULL
,	NULL
=	NULL
3.9	NULL
pM	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/RelA	NULL
(	NULL
p65	NULL
)	NULL
for	NULL
this	NULL
site	NULL
is	NULL
~-6-fold	NULL
higher	NULL
(	NULL
K	NULL
,	NULL
,	NULL
=	NULL
11.8	NULL
pM	NULL
)	NULL
than	NULL
that	NULL
of	NULL
p49	NULL
alone	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
in	NULL
vitro	NULL
transcription	NULL
was	NULL
stimulated	NULL
18-fold	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
preformed	NULL
,	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIlA	NULL
(	NULL
p65	NULL
)	NULL
protein	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
was	NULL
also	NULL
subject	NULL
to	NULL
regulation	NULL
by	NULL
recently	NULL
cloned	NULL
IxB-	NULL
«	NULL
(	NULL
MAD-3	NULL
)	NULL
.	NULL

Recombinant	NULL
IB-	NULL
«	NULL
(	NULL
MAD-3	NULL
)	NULL
inhibited	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
p65	NULL
,	NULL
p49/p65	NULL
,	NULL
and	NULL
p50/p65	NULL
but	NULL
stimulated	NULL
the	NULL
binding	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
or	NULL
NFKB1	NULL
(	NULL
pS50	NULL
)	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
an	NULL
HIV	NULL
reporter	NULL
plasmid	NULL
by	NULL
p49/p65	NULL
in	NULL
transiently	NULL
transfected	NULL
Jurkat	NULL
T-leukemia	NULL
cells	NULL
was	NULL
also	NULL
inhibited	NULL
by	NULL
coexpression	NULL
of	NULL
MAD-3	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
NFKB2	NULL
subunit	NULL
to	NULL
the	NULL
HIV	NULL
enhancer	NULL
is	NULL
facilitated	NULL
by	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
that	NULL
this	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/p65	NULL
heterodimeric	NULL
complex	NULL
mediates	NULL
transcriptional	NULL
activation	NULL
which	NULL
is	NULL
subject	NULL
to	NULL
regulation	NULL
by	NULL
MAD-3	NULL
.	NULL

Nuclear	NULL
factor	NULL
xB	NULL
(	NULL
NF-KB	NULL
)	NULL
is	NULL
a	NULL
family	NULL
of	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
which	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
26	NULL
)	NULL
.	NULL

These	NULL
transcription	NULL
factors	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
many	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
in	NULL
association	NULL
with	NULL
IxB	NULL
's	NULL
,	NULL
factors	NULL
which	NULL
inhibit	NULL
their	NULL
DNA-binding	NULL
activity	NULL
(	NULL
2	NULL
,	NULL
47	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
can	NULL
be	NULL
stimulated	NULL
by	NULL
cellular	NULL
activation	NULL
with	NULL
cytokines	NULL
(	NULL
37	NULL
)	NULL
or	NULL
viral	NULL
trans-activators	NULL
(	NULL
6	NULL
,	NULL
28	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Cellular	NULL
protein	NULL
kinases	NULL
can	NULL
alter	NULL
the	NULL
phosphorylation	NULL
of	NULL
IKB	NULL
's	NULL
(	NULL
13	NULL
,	NULL
29	NULL
)	NULL
,	NULL
leading	NULL
them	NULL
to	NULL
dissociate	NULL
from	NULL
NF-kB	NULL
.	NULL

This	NULL
dissociation	NULL
is	NULL
likely	NULL
to	NULL
serve	NULL
as	NULL
an	NULL
important	NULL
regulatory	NULL
step	NULL
which	NULL
makes	NULL
NF-	NULL
«	NULL
B	NULL
available	NULL
for	NULL
binding	NULL
to	NULL
«	NULL
B	NULL
elements	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
cellular	NULL
genes	NULL
,	NULL
NF-KB	NULL
can	NULL
also	NULL
activate	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
encoded	NULL
by	NULL
eukaryotic	NULL
viruses	NULL
.	NULL

Among	NULL
these	NULL
,	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
enhancer	NULL
contains	NULL
two	NULL
«	NULL
B	NULL
sites	NULL
which	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
inducible	NULL
activation	NULL
of	NULL
viral	NULL
transcription	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Biochemical	NULL
and	NULL
molecular	NULL
biological	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
begun	NULL
to	NULL
reveal	NULL
the	NULL
complexity	NULL
of	NULL
this	NULL
transcriptional	NULL
regulatory	NULL
pathway	NULL
.	NULL

Highly	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
major	NULL
subunits	NULL
,	NULL
with	NULL
molecular	NULL
masses	NULL
of	NULL
~50	NULL
and	NULL
~65	NULL
kDa	NULL
,	NULL
respectively	NULL
(	NULL
4	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
cDNAs	NULL
encoding	NULL
the	NULL
50-kDa	NULL
subunit	NULL
(	NULL
p50	NULL
)	NULL
suggested	NULL
that	NULL
the	NULL
primary	NULL
translation	NULL
product	NULL
of	NULL
this	NULL
subunit	NULL
is	NULL
a	NULL
~105-kDa	NULL
protein	NULL
which	NULL
requires	NULL
posttranslational	NULL
modification	NULL
to	NULL
obtain	NULL
the	NULL
mature	NULL
form	NULL
(	NULL
8	NULL
,	NULL
14	NULL
,	NULL
22	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Sequence	NULL
comparison	NULL
of	NULL
p50	NULL
and	NULL
the	NULL
gene	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

1315	NULL
encoding	NULL
the	NULL
65-kDa	NULL
subunit	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
36	NULL
,	NULL
40	NULL
)	NULL
revealed	NULL
a	NULL
high	NULL
homology	NULL
to	NULL
the	NULL
c-re/	NULL
proto-oncogene	NULL
(	NULL
9	NULL
)	NULL
and	NULL
to	NULL
the	NULL
Dros-ophila	NULL
morphogen	NULL
dorsal	NULL
(	NULL
44	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
described	NULL
another	NULL
gene	NULL
,	NULL
p49/p100	NULL
,	NULL
which	NULL
can	NULL
generate	NULL
an	NULL
alternative	NULL
~50-kDa	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
7	NULL
,	NULL
34	NULL
,	NULL
43	NULL
)	NULL
.	NULL

A	NULL
~50-kDa	NULL
protein	NULL
can	NULL
be	NULL
generated	NULL
either	NULL
by	NULL
posttranslational	NULL
processing	NULL
of	NULL
a	NULL
~100-kDa	NULL
precursor	NULL
or	NULL
by	NULL
the	NULL
generation	NULL
of	NULL
an	NULL
alternatively	NULL
spliced	NULL
form	NULL
,	NULL
p49	NULL
;	NULL
the	NULL
N	NULL
termini	NULL
of	NULL
p49	NULL
and	NULL
p100	NULL
are	NULL
identical	NULL
,	NULL
and	NULL
p49	NULL
appears	NULL
to	NULL
be	NULL
functionally	NULL
indistinguishable	NULL
from	NULL
truncated	NULL
forms	NULL
of	NULL
p100	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
gene	NULL
encoding	NULL
this	NULL
product	NULL
has	NULL
been	NULL
designated	NULL
NFKB2	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
p105	NULL
subunit	NULL
,	NULL
which	NULL
has	NULL
been	NULL
termed	NULL
NFKB1	NULL
(	NULL
30a	NULL
)	NULL
.	NULL

A	NULL
human	NULL
cDNA	NULL
clone	NULL
that	NULL
encodes	NULL
a	NULL
35-	NULL
to	NULL
37-kDa	NULL
protein	NULL
has	NULL
been	NULL
isolated	NULL
.	NULL

The	NULL
protein	NULL
,	NULL
MAD-3	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
I	NULL
«	NULL
B-like	NULL
properties	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Purification	NULL
and	NULL
primary	NULL
sequence	NULL
analysis	NULL
of	NULL
rabbit	NULL
IxB	NULL
(	NULL
10	NULL
)	NULL
has	NULL
revealed	NULL
its	NULL
identity	NULL
to	NULL
MAD-3	NULL
.	NULL

The	NULL
MAD-3/I	NULL
«	NULL
B	NULL
protein	NULL
contains	NULL
five	NULL
repeats	NULL
of	NULL
a	NULL
sequence	NULL
that	NULL
was	NULL
first	NULL
identified	NULL
in	NULL
the	NULL
erythroid	NULL
protein	NULL
ankyrin	NULL
and	NULL
is	NULL
also	NULL
present	NULL
in	NULL
a	NULL
number	NULL
of	NULL
proteins	NULL
involved	NULL
in	NULL
cell	NULL
cycle	NULL
control	NULL
and	NULL
tissue	NULL
differentiation	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
C	NULL
termini	NULL
of	NULL
p100	NULL
and	NULL
p105	NULL
also	NULL
contain	NULL
ankyrin/cell	NULL
cycle	NULL
repeats	NULL
,	NULL
and	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
p105	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
IxB-like	NULL
activity	NULL
when	NULL
expressed	NULL
in	NULL
trans	NULL
(	NULL
17	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Cotransfection	NULL
studies	NULL
with	NULL
p50	NULL
NFKB1	NULL
and	NULL
p49	NULL
NFKB2	NULL
expression	NULL
vectors	NULL
have	NULL
shown	NULL
that	NULL
these	NULL
two	NULL
genes	NULL
,	NULL
despite	NULL
their	NULL
homology	NULL
,	NULL
differ	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
«	NULL
B-dependent	NULL
transcription	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
in	NULL
combination	NULL
with	NULL
RelA	NULL
{	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
38	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
characterize	NULL
the	NULL
biochemical	NULL
properties	NULL
of	NULL
recombinant	NULL
p49	NULL
as	NULL
well	NULL
as	NULL
its	NULL
interactions	NULL
with	NULL
p65	NULL
and	NULL
with	NULL
MAD-3	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
constants	NULL
of	NULL
p49	NULL
1316	NULL
DUCKETT	NULL
ET	NULL
AL	NULL
.	NULL

homodimers	NULL
and	NULL
p49/p65	NULL
heterodimers	NULL
to	NULL
both	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
and	NULL
the	NULL
related	NULL
H-2	NULL
site	NULL
(	NULL
5	NULL
,	NULL
18	NULL
)	NULL
are	NULL
determined	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/Re	NULL
!	NULL

IA	NULL
(	NULL
p65	NULL
)	NULL
proteins	NULL
to	NULL
stimulate	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
is	NULL
characterized	NULL
.	NULL

We	NULL
show	NULL
that	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/RelA	NULL
(	NULL
p65	NULL
)	NULL
has	NULL
a	NULL
higher	NULL
affinity	NULL
for	NULL
«	NULL
B	NULL
than	NULL
does	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
,	NULL
stimulates	NULL
transcription	NULL
of	NULL
HIV	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
is	NULL
subject	NULL
to	NULL
regulation	NULL
by	NULL
IxB-	NULL
«	NULL
/MAD-3	NULL
mediated	NULL
through	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
subunit	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

Human	NULL
p50	NULL
NFKB2	NULL
,	NULL
a	NULL
~50-kDa	NULL
N-terminal	NULL
truncated	NULL
form	NULL
of	NULL
p105	NULL
,	NULL
was	NULL
generated	NULL
from	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
-p105	NULL
by	NULL
using	NULL
site-directed	NULL
mutagenesis	NULL
to	NULL
create	NULL
a	NULL
stop	NULL
codon	NULL
at	NULL
the	NULL
position	NULL
corresponding	NULL
to	NULL
residue	NULL
453	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
BgilI	NULL
restriction	NULL
site	NULL
.	NULL

Utilization	NULL
of	NULL
the	NULL
previously	NULL
created	NULL
HindIII	NULL
and	NULL
Neo	NULL
!	NULL

sites	NULL
5	NULL
of	NULL
the	NULL
Kozak	NULL
sequence	NULL
(	NULL
23	NULL
)	NULL
of	NULL
RSV-p105	NULL
(	NULL
38	NULL
)	NULL
allowed	NULL
subcloning	NULL
into	NULL
the	NULL
RSV	NULL
and	NULL
pET3D	NULL
vectors	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Human	NULL
p65	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
B-cell	NULL
lymphoma	NULL
cDNA	NULL
library	NULL
probed	NULL
with	NULL
a	NULL
polymerase	NULL
chain	NULL
reaction-derived	NULL
mouse	NULL
p65	NULL
cDNA	NULL
clone	NULL
.	NULL

The	NULL
human	NULL
clone	NULL
appears	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
that	NULL
described	NULL
previously	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

3	NULL
'	NULL
untrans-lated	NULL
sequence	NULL
was	NULL
removed	NULL
by	NULL
digestion	NULL
with	NULL
BsaHI	NULL
,	NULL
and	NULL
the	NULL
5	NULL
'	NULL
overhang	NULL
was	NULL
filled	NULL
in	NULL
with	NULL
Klenow	NULL
enzyme	NULL
.	NULL

The	NULL
Ncol	NULL
site	NULL
at	NULL
the	NULL
initiation	NULL
ATG	NULL
was	NULL
used	NULL
to	NULL
subclone	NULL
into	NULL
the	NULL
modified	NULL
RSV	NULL
-globin	NULL
vector	NULL
(	NULL
43	NULL
)	NULL
,	NULL
thus	NULL
inserting	NULL
a	NULL
consensus	NULL
Kozak	NULL
sequence	NULL
.	NULL

The	NULL
MAD-3	NULL
cDNA	NULL
(	NULL
16	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Chiron	NULL
Inc.	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
modified	NULL
RSV	NULL
vector	NULL
(	NULL
43	NULL
)	NULL
by	NULL
ligation	NULL
of	NULL
an	NULL
Xbel-Klenow-HindIII	NULL
MAD-3	NULL
fragment	NULL
into	NULL
the	NULL
modified	NULL
RSV	NULL
B-globin-derived	NULL
backbone	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
in	NULL
vitro	NULL
transcription	NULL
template	NULL
(	NULL
pHIV380	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
blunt-end	NULL
ligation	NULL
of	NULL
a	NULL
~730-bp	NULL
Xhol-Hindlll	NULL
Klenow-treated	NULL
fragment	NULL
from	NULL
an	NULL
HIV-chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
construct	NULL
into	NULL
the	NULL
SacI	NULL
site	NULL
of	NULL
the	NULL
p	NULL
(	NULL
C	NULL
,	NULL
AT	NULL
)	NULL
:	NULL
,	NULL
G-less	NULL
cassette	NULL
vector	NULL
(	NULL
42	NULL
)	NULL
,	NULL
whose	NULL
3	NULL
'	NULL
overhangs	NULL
had	NULL
been	NULL
removed	NULL
by	NULL
treatment	NULL
with	NULL
T4	NULL
polymerase	NULL
.	NULL

The	NULL
adenovirus	NULL
major	NULL
late	NULL
plasmid	NULL
,	NULL
pML200	NULL
(	NULL
31	NULL
)	NULL
,	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
U.	NULL
Schibler	NULL
,	NULL
University	NULL
of	NULL
Geneva	NULL
.	NULL

All	NULL
other	NULL
expression	NULL
vectors	NULL
and	NULL
«	NULL
B	NULL
reporter	NULL
plasmids	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Protein	NULL
purification	NULL
and	NULL
formation	NULL
of	NULL
heterodimers	NULL
.	NULL

p49	NULL
and	NULL
p50	NULL
proteins	NULL
were	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
LysE	NULL
)	NULL
and	NULL
partially	NULL
purified	NULL
by	NULL
Sephacryl	NULL
S-200	NULL
gel	NULL
filtration	NULL
fast	NULL
protein	NULL
liquid	NULL
chromatography	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
affinity	NULL
purified	NULL
by	NULL
oligonucleotide	NULL
chromatography	NULL
(	NULL
19	NULL
)	NULL
,	NULL
using	NULL
the	NULL
H-2	NULL
site	NULL
as	NULL
the	NULL
target	NULL
sequence	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
eluted	NULL
with	NULL
a	NULL
linear	NULL
NaCl	NULL
gradient	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N	NULL
'	NULL
-2-ethane-sulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
ZnCl	NULL
,	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
phenyl-methylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
dialyzed	NULL
against	NULL
the	NULL
same	NULL
buffer	NULL
with	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
stored	NULL
in	NULL
aliquots	NULL
at	NULL
-70°C	NULL
.	NULL

Proteins	NULL
were	NULL
judged	NULL
to	NULL
be	NULL
at	NULL
least	NULL
90	NULL
%	NULL
pure	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
analysis	NULL
.	NULL

Heterodimers	NULL
were	NULL
formed	NULL
by	NULL
incubating	NULL
concentrated	NULL
proteins	NULL
in	NULL
a	NULL
3-	NULL
,	NULL
l	NULL
volume	NULL
for	NULL
15	NULL
to	NULL
40	NULL
min	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
diluting	NULL
the	NULL
mixture	NULL
in	NULL
the	NULL
same	NULL
dialysis	NULL
buffer	NULL
containing	NULL
0.1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
.	NULL

Recombinant	NULL
murine	NULL
p65	NULL
protein	NULL
,	NULL
expressed	NULL
in	NULL
baculovi-rus	NULL
(	NULL
11	NULL
)	NULL
,	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
T.	NULL
Fujita	NULL
,	NULL
G.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Brot	NULL
.	NULL

Expression	NULL
and	NULL
purification	NULL
of	NULL
MAD-3	NULL
protein	NULL
as	NULL
a	NULL
fusion	NULL
protein	NULL
with	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
will	NULL
be	NULL
described	NULL
elsewhere	NULL
(	NULL
222	NULL
)	NULL
.	NULL

EMSA	NULL
and	NULL
chemical	NULL
cross-linking	NULL
.	NULL

Proteins	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
DNA	NULL
probes	NULL
in	NULL
a	NULL
20-pul	NULL
reaction	NULL
mixture	NULL
containing	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
,	NULL
3	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
wM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
10	NULL
wM	NULL
ATP	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
4	NULL
%	NULL
nonde-naturing	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.25	NULL
%	NULL
Tris-borate-EDTA	NULL
at	NULL
10	NULL
V/cm	NULL
for	NULL
5	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Dried	NULL
gels	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
at	NULL
-70°C	NULL
with	NULL
intensifying	NULL
screens	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
(	NULL
i	NULL
)	NULL
a	NULL
182-bp	NULL
Scal-Nhel	NULL
restriction	NULL
fragment	NULL
from	NULL
an	NULL
HIV-1	NULL
LTR	NULL
plasmid	NULL
in	NULL
which	NULL
site-directed	NULL
mutagenesis	NULL
had	NULL
been	NULL
used	NULL
to	NULL
abolish	NULL
the	NULL
3	NULL
'	NULL
KB	NULL
site	NULL
to	NULL
eliminate	NULL
the	NULL
possibility	NULL
of	NULL
cooperative	NULL
binding	NULL
and	NULL
double	NULL
occupancy	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
encoding	NULL
a	NULL
single	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
5'-AGCTTGGGGACTTTCCACTAGTACG-3	NULL
'	NULL
3'-ACCCCTGAAAGGTGATCATGCTTAA-S5	NULL
'	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
,	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
encoding	NULL
a	NULL
single	NULL
KB	NULL
site	NULL
and	NULL
a	NULL
single	NULL
adjacent	NULL
Spl	NULL
site	NULL
from	NULL
the	NULL
HIV	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
5'-GATCCOGCTGGGGACTTTCCAGGGAGGCGTGCGCCTGA-3	NULL
'	NULL
3'-GCGACCCCTGAAAGGTCCCTCCGCACCGGACTCTAG-5	NULL
'	NULL
The	NULL
«	NULL
B	NULL
motifs	NULL
are	NULL
shown	NULL
in	NULL
bold	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
radiolabeled	NULL
by	NULL
using	NULL
Klenow	NULL
enzyme	NULL
and	NULL
[	NULL
°°P	NULL
]	NULL
dCTP	NULL
;	NULL
~0.5	NULL
ng	NULL
was	NULL
used	NULL
in	NULL
a	NULL
standard	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
reaction	NULL
.	NULL

For	NULL
cross-linking	NULL
,	NULL
purified	NULL
homodimeric	NULL
and	NULL
heterodimeric	NULL
proteins	NULL
(	NULL
200	NULL
to	NULL
1,600	NULL
ng	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
4-ethyl-eneglycol	NULL
bis	NULL
(	NULL
sulfosuccinimidyl	NULL
succinate	NULL
)	NULL
(	NULL
EGS	NULL
;	NULL
Pierce	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
40-p.l	NULL
volume	NULL
in	NULL
the	NULL
dilution	NULL
buffer	NULL
described	NULL
above	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
p-lysine	NULL
(	NULL
25	NULL
mM	NULL
,	NULL
final	NULL
concentration	NULL
)	NULL
,	NULL
and	NULL
one	NULL
half	NULL
of	NULL
each	NULL
sample	NULL
was	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
SDS-6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-p100	NULL
polyclonal	NULL
antibody	NULL
(	NULL
38a	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
goat	NULL
anti-rabbit	NULL
horseradish	NULL
peroxidase	NULL
conjugate	NULL
;	NULL
the	NULL
reaction	NULL
was	NULL
developed	NULL
by	NULL
using	NULL
the	NULL
ECL	NULL
Western	NULL
immunoblotting	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Determination	NULL
of	NULL
dissociation	NULL
constants	NULL
.	NULL

Dissociation	NULL
constants	NULL
were	NULL
determined	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Gel-purified	NULL
oligonucleotides	NULL
encoding	NULL
either	NULL
the	NULL
HIV	NULL
or	NULL
H-2	NULL
«	NULL
B	NULL
site	NULL
,	NULL
with	NULL
T	NULL
overhangs	NULL
and	NULL
C	NULL
ends	NULL
,	NULL
were	NULL
used	NULL
as	NULL
follows	NULL
:	NULL
HIV	NULL
xB	NULL
probe	NULL
,	NULL
5'-CCTTTTTTTTTTAGGGGACTTTCCGA-3	NULL
'	NULL
3'-TCCCCTGAAAGGCTTTTTTTTTTTCC-S	NULL
'	NULL
H-2	NULL
probe	NULL
,	NULL
5-CCTTTTTTTTTTAGGGGATTCCCCGA-3	NULL
'	NULL
3'-TCCCCTAAGGGGCTTTTTTTTTTTCC-S	NULL
'	NULL
The	NULL
«	NULL
B	NULL
elements	NULL
are	NULL
shown	NULL
in	NULL
bold	NULL
.	NULL

Annealed	NULL
oligonucleotides	NULL
were	NULL
radiolabeled	NULL
with	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
dATP	NULL
by	NULL
using	NULL
Klenow	NULL
enzyme	NULL
and	NULL
chased	NULL
with	NULL
unlabeled	NULL
dATP	NULL
and	NULL
dGTP	NULL
.	NULL

Unin-corporated	NULL
radionucleotides	NULL
were	NULL
removed	NULL
by	NULL
Sephadex	NULL
G-50	NULL
gel	NULL
filtration	NULL
.	NULL

Probes	NULL
used	NULL
were	NULL
of	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
at	NULL
least	NULL
50,000	NULL
Ci/mmol	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
active	NULL
DNA-binding	NULL
sites	NULL
was	NULL
calculated	NULL
by	NULL
EMSA	NULL
analysis	NULL
using	NULL
a	NULL
large	NULL
excess	NULL
of	NULL
probe	NULL
,	NULL
and	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
protein	NULL
(	NULL
~1	NULL
fmol	NULL
)	NULL
VoL	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
p49/	NULL
p50/	NULL
p49	NULL
p65	NULL
p50	NULL
p65	NULL
p65	NULL
ta	NULL
#	NULL
#	NULL
6	NULL
%	NULL
¢	NULL
»	NULL
#	NULL
»	NULL
tug	NULL
be	NULL
>	NULL
-	NULL
buy	NULL
_	NULL
t	NULL
..	NULL
&	NULL
a	NULL
6	NULL
7	NULL
.	NULL

8	NULL
9	NULL
thous	NULL
tout	NULL
ta	NULL
)	NULL
»	NULL
»	NULL
but	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
TRANSCRIPTIONAL	NULL
REGULATION	NULL
BY	NULL
NFKB2	NULL
AND	NULL
IkB-	NULL
«	NULL
1317	NULL
C.	NULL
p50	NULL
Protein	NULL
:	NULL
p49	NULL
p49	NULL
pgg/	NULL
p	NULL
Cima	NULL
.	NULL

EGS	NULL
:	NULL
-	NULL
+	NULL
+	NULL
<	NULL
4	NULL
180-	NULL
,	NULL
«	NULL
3	NULL
10	NULL
11	NULL
ne	NULL
H	NULL
``	NULL
<	NULL
5	NULL
84-58-	NULL
t	NULL
-	NULL
1	NULL
48.5-	NULL
12	NULL
13	NULL
14	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Formation	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
multimers	NULL
in	NULL
vitro	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
,	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
proteins	NULL
were	NULL
incubated	NULL
as	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
0.25	NULL
ng/2	NULL
ng	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
alone	NULL
(	NULL
0.12	NULL
ng	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
heterodimeric	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
0.12	NULL
ng/0.8	NULL
ng	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
an	NULL
excess	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
4	NULL
ng	NULL
)	NULL
to	NULL
compare	NULL
its	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
radiolabeled	NULL
restriction	NULL
fragment	NULL
derived	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
was	NULL
used	NULL
under	NULL
standard	NULL
conditions	NULL
,	NULL
except	NULL
that	NULL
reaction	NULL
mixtures	NULL
contained	NULL
100	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Formation	NULL
of	NULL
higher-order	NULL
complexes	NULL
at	NULL
high	NULL
protein	NULL
concentration	NULL
.	NULL

Serial	NULL
dilutions	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
(	NULL
50	NULL
,	NULL
5	NULL
,	NULL
and	NULL
0.5	NULL
ng	NULL
;	NULL
lanes	NULL
6	NULL
to	NULL
8	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
(	NULL
25	NULL
,	NULL
2.5	NULL
,	NULL
and	NULL
0.25	NULL
ng	NULL
;	NULL
lanes	NULL
9	NULL
to	NULL
11	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
radiolabeled	NULL
HIV	NULL
xB	NULL
probe	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
under	NULL
standard	NULL
conditions	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Chemical	NULL
cross-linking	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
.	NULL

NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
EGS	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
with	NULL
a	NULL
polyclonal	NULL
antibody	NULL
specific	NULL
to	NULL
p49/p100	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Positions	NULL
of	NULL
native	NULL
(	NULL
arrow	NULL
1	NULL
)	NULL
and	NULL
cross-linked	NULL
(	NULL
arrows	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
)	NULL
species	NULL
are	NULL
indicated	NULL
.	NULL

was	NULL
incubated	NULL
with	NULL
a	NULL
range	NULL
of	NULL
probe	NULL
concentrations	NULL
in	NULL
a	NULL
10-pul	NULL
reaction	NULL
for	NULL
10	NULL
min	NULL
under	NULL
standard	NULL
EMSA	NULL
conditions	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Dried	NULL
gels	NULL
were	NULL
analyzed	NULL
by	NULL
using	NULL
a	NULL
Betascope	NULL
analyzer	NULL
(	NULL
Betagen	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
HeLaScribe	NULL
;	NULL
Promega	NULL
)	NULL
.	NULL

Extracts	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
at	NULL
30°C	NULL
for	NULL
30	NULL
min	NULL
in	NULL
a	NULL
25-ul	NULL
reaction	NULL
volume	NULL
containing	NULL
ATP	NULL
and	NULL
CTP	NULL
(	NULL
all	NULL
at	NULL
0.4	NULL
mM	NULL
)	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
[	NULL
«	NULL
-*PJUTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
)	NULL
,	NULL
7.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
100	NULL
ng	NULL
each	NULL
of	NULL
plasmids	NULL
pHIV380	NULL
and	NULL
pML200	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
8	NULL
%	NULL
glycerol	NULL
.	NULL

RNase	NULL
T	NULL
,	NULL
(	NULL
150	NULL
U	NULL
;	NULL
Bio-Rad	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
15	NULL
min	NULL
.	NULL

RNA	NULL
was	NULL
recovered	NULL
by	NULL
phenol-chloroform	NULL
extraction	NULL
followed	NULL
by	NULL
ethanol	NULL
precipitation	NULL
and	NULL
resolved	NULL
on	NULL
6	NULL
%	NULL
sequencing	NULL
gels	NULL
.	NULL

Dried	NULL
gels	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
at	NULL
-70°C	NULL
with	NULL
intensifying	NULL
screens	NULL
,	NULL
and	NULL
autoradiograms	NULL
were	NULL
analyzed	NULL
by	NULL
digital	NULL
scan-ning	NULL
,	NULL
using	NULL
hardware	NULL
and	NULL
software	NULL
from	NULL
Biolmage	NULL
Inc.	NULL
(	NULL
Ann	NULL
Arbor	NULL
,	NULL
Mich.	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Cell	NULL
culture	NULL
,	NULL
transfections	NULL
,	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
43	NULL
)	NULL
.	NULL

RESULTS	NULL
Dimerization	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
properties	NULL
of	NULL
recombinant	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
were	NULL
compared	NULL
by	NULL
using	NULL
the	NULL
EMSA	NULL
.	NULL

When	NULL
purified	NULL
,	NULL
recombinant	NULL
p49	NULL
protein	NULL
was	NULL
combined	NULL
with	NULL
recombinant	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
an	NULL
HIV	NULL
B	NULL
site	NULL
probe	NULL
,	NULL
a	NULL
novel	NULL
complex	NULL
with	NULL
a	NULL
mobility	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
either	NULL
subunit	NULL
alone	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
2	NULL
versus	NULL
1	NULL
and	NULL
5	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
complex	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
findings	NULL
that	NULL
both	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
can	NULL
form	NULL
heterodimeric	NULL
complexes	NULL
with	NULL
Re-1A¥	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
7	NULL
,	NULL
36	NULL
,	NULL
38	NULL
)	NULL
.	NULL

At	NULL
high	NULL
protein	NULL
concentrations	NULL
of	NULL
p49	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
8	NULL
)	NULL
and	NULL
p50	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
9	NULL
to	NULL
11	NULL
)	NULL
,	NULL
complexes	NULL
with	NULL
lower	NULL
mobility	NULL
were	NULL
observed	NULL
,	NULL
suggesting	NULL
that	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
are	NULL
able	NULL
to	NULL
form	NULL
higher-order	NULL
oligomers	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
observation	NULL
further	NULL
,	NULL
the	NULL
p49-containing	NULL
complexes	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
bifunc-tional	NULL
chemical	NULL
cross-linking	NULL
agent	NULL
EGS	NULL
,	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
antiserum	NULL
specific	NULL
to	NULL
p49	NULL
.	NULL

While	NULL
native	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
migrated	NULL
as	NULL
predicted	NULL
by	NULL
its	NULL
molecular	NULL
weight	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
12	NULL
,	NULL
arrow	NULL
1	NULL
)	NULL
,	NULL
cross-linked	NULL
protein	NULL
migrated	NULL
predominantly	NULL
as	NULL
a	NULL
~100-kDa	NULL
species	NULL
,	NULL
while	NULL
a	NULL
minor	NULL
~200-kDa	NULL
band	NULL
was	NULL
also	NULL
present	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
13	NULL
,	NULL
arrows	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
NFKB2	NULL
exists	NULL
predominantly	NULL
in	NULL
a	NULL
dimeric	NULL
form	NULL
in	NULL
solution	NULL
.	NULL

Cross-linked	NULL
heterodimeric	NULL
NFKB2/ReIA	NULL
migrated	NULL
at	NULL
a	NULL
position	NULL
consisten	NULL
'	NULL
with	NULL
the	NULL
predicted	NULL
size	NULL
of	NULL
the	NULL
heterodimer	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
14	NULL
,	NULL
arrow	NULL
3	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
DNA-binding	NULL
properties	NULL
of	NULL
NFKB2	NULL
,	NULL
the	NULL
dissociation	NULL
constants	NULL
of	NULL
binding	NULL
to	NULL
different	NULL
kB	NULL
sites	NULL
were	NULL
determined	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
radiolabeled	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
,	NULL
and	NULL
dilutions	NULL
of	NULL
probe	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
constant	NULL
concentration	NULL
of	NULL
protein	NULL
.	NULL

Bound	NULL
and	NULL
free	NULL
DNA	NULL
species	NULL
were	NULL
resolved	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
dissociation	NULL
constants	NULL
were	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
homodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
for	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
was	NULL
approximately	NULL
18	NULL
times	NULL
weaker	NULL
than	NULL
that	NULL
of	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
homodimeric	NULL
p49	NULL
showed	NULL
a	NULL
higher	NULL
affinity	NULL
for	NULL
the	NULL
H-2	NULL
«	NULL
kB	NULL
element	NULL
than	NULL
for	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
in	NULL
which	NULL
this	NULL
1318	NULL
DUCKETT	NULL
ET	NULL
AL	NULL
.	NULL

[	NULL
8	NULL
]	NULL
/	NULL
(	NULL
F	NULL
]	NULL
[	NULL
B	NULL
]	NULL
(	NULL
pM	NULL
)	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Affinity	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
for	NULL
the	NULL
HIV	NULL
kB	NULL
site	NULL
.	NULL

To	NULL
determine	NULL
dissociation	NULL
constants	NULL
of	NULL
homodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
(	NULL
GGG	NULL
GACTTTCC	NULL
)	NULL
site	NULL
,	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
purified	NULL
subunit	NULL
(	NULL
~1	NULL
fmol	NULL
active	NULL
protein	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
range	NULL
of	NULL
radiolabeled	NULL
probe	NULL
concentrations	NULL
,	NULL
in	NULL
a	NULL
10-pl	NULL
reaction	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Bound	NULL
(	NULL
B	NULL
)	NULL
and	NULL
free	NULL
(	NULL
F	NULL
)	NULL
probe	NULL
species	NULL
were	NULL
quantitated	NULL
by	NULL
using	NULL
a	NULL
Betascope	NULL
analyzer	NULL
(	NULL
Betagen	NULL
)	NULL
,	NULL
and	NULL
dissociation	NULL
constants	NULL
were	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
.	NULL

Reactions	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

difference	NULL
had	NULL
not	NULL
been	NULL
quantitated	NULL
(	NULL
7	NULL
,	NULL
34	NULL
,	NULL
38	NULL
)	NULL
.	NULL

However	NULL
,	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
showed	NULL
a	NULL
five-	NULL
to	NULL
sixfold-higher	NULL
affinity	NULL
for	NULL
the	NULL
HIV	NULL
site	NULL
than	NULL
did	NULL
p49	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
association	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
increased	NULL
its	NULL
affinity	NULL
for	NULL
the	NULL
palindromic	NULL
H-2	NULL
xB	NULL
site	NULL
less	NULL
than	NULL
twofold	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
heterodimers	NULL
stimulate	NULL
HIV	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/	NULL
RelA	NULL
{	NULL
(	NULL
p65	NULL
)	NULL
protein	NULL
on	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
HIV	NULL
was	NULL
examined	NULL
in	NULL
vitro	NULL
by	NULL
using	NULL
a	NULL
reporter	NULL
plasmid	NULL
in	NULL
which	NULL
the	NULL
HIV	NULL
LTR	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
synthetic	NULL
(	NULL
C	NULL
;	NULL
AT	NULL
)	NULL
q	NULL
cassette	NULL
(	NULL
42	NULL
)	NULL
to	NULL
allow	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
~380-nucleotide	NULL
RNA	NULL
transcript	NULL
lacking	NULL
guanosine	NULL
residues	NULL
.	NULL

LTR-directed	NULL
transcription	NULL
was	NULL
monitored	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
HeLa	NULL
pa9/85	NULL
Kd=11.8pM	NULL
[	NULL
B	NULL
]	NULL
/	NULL
[	NULL
F	NULL
]	NULL
p49	NULL
a	NULL
Kd=69.1pM	NULL
[	NULL
B	NULL
]	NULL
(	NULL
PM	NULL
)	NULL
[	NULL
8	NULL
]	NULL
/	NULL
[	NULL
F	NULL
]	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro..	NULL
p49	NULL
+	NULL
=	NULL
p49	NULL
p65	NULL
p65	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Analysis	NULL
of	NULL
HIV	NULL
transcription	NULL
by	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
in	NULL
vitro	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
ng	NULL
each	NULL
of	NULL
plasmids	NULL
pHIV380	NULL
and	NULL
pML200	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RNase	NULL
T	NULL
;	NULL
and	NULL
[	NULL
«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
UTP	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
along	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
recombinant	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
proteins	NULL
as	NULL
indicated	NULL
.	NULL

RNA	NULL
transcripts	NULL
were	NULL
recovered	NULL
and	NULL
analyzed	NULL
on	NULL
6	NULL
%	NULL
sequencing	NULL
gels	NULL
.	NULL

AdML	NULL
,	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
.	NULL

cells	NULL
programmed	NULL
with	NULL
the	NULL
HIV	NULL
plasmid	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RNase	NULL
T	NULL
,	NULL
,	NULL
which	NULL
rapidly	NULL
degrades	NULL
all	NULL
G-containing	NULL
tran-scripts	NULL
.	NULL

Addition	NULL
of	NULL
preformed	NULL
,	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
stimulated	NULL
transcription	NULL
of	NULL
HIV	NULL
up	NULL
to	NULL
18-fold	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
while	NULL
addition	NULL
of	NULL
a	NULL
similar	NULL
quantity	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
or	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
alone	NULL
stimulated	NULL
HIV	NULL
transcription	NULL
only	NULL
1.4-fold	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
6.8-fold	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
digital	NULL
scanning	NULL
analysis	NULL
of	NULL
the	NULL
autoradiogram	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Transcription	NULL
of	NULL
a	NULL
~200-bp	NULL
cassette	NULL
driven	NULL
by	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
proteins	NULL
.	NULL

Binding	NULL
of	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
to	NULL
DNA	NULL
is	NULL
blocked	NULL
by	NULL
MAD-3	NULL
protein	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
MAD-3	NULL
gene	NULL
product	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
was	NULL
next	NULL
examined	NULL
.	NULL

Recombinant	NULL
MAD-3	NULL
protein	NULL
,	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
and	NULL
purified	NULL
as	NULL
a	NULL
fusion	NULL
protein	NULL
with	NULL
GST	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Addition	NULL
of	NULL
GST-MAD-3	NULL
protein	NULL
inhibited	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Recombinant	NULL
MAD-3	NULL
protein	NULL
had	NULL
no	NULL
inhibitory	NULL
effect	NULL
on	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
or	NULL
NFKBI	NULL
(	NULL
p50	NULL
)	NULL
binding	NULL
alone	NULL
and	NULL
in	NULL
fact	NULL
stimulated	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
homodimeric	NULL
p49	NULL
and	NULL
p50	NULL
p4	NULL
14	NULL
Kd=15.7pM	NULL
[	NULL
B	NULL
]	NULL
(	NULL
PM	NULL
)	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Comparison	NULL
of	NULL
affinities	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
for	NULL
the	NULL
HIV	NULL
or	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
complex	NULL
«	NULL
B	NULL
sites	NULL
by	NULL
Scatchard	NULL
analysis	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
HIV	NULL
(	NULL
GGGGACTTTCC	NULL
)	NULL
(	NULL
A	NULL
)	NULL
and	NULL
H-2	NULL
kB	NULL
(	NULL
GGGGAATCCCC	NULL
)	NULL
(	NULL
B	NULL
)	NULL
sites	NULL
.	NULL

NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
heterodimers	NULL
were	NULL
formed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
dissociation	NULL
constants	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

B	NULL
,	NULL
bound	NULL
probe	NULL
;	NULL
F	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
Protein	NULL
:	NULL
p65	NULL
p49	NULL
$	NULL
323	NULL
?	NULL

p50	NULL
Egg	NULL
Sp1	NULL
~	NULL
inx	NULL
.	NULL

=	NULL
*a	NULL
joue	NULL
meen	NULL
:	NULL
gtr	NULL
poe	NULL
eet	NULL
yue	NULL
n	NULL
-	NULL
go-	NULL
$	NULL
o-	NULL
go-	NULL
go-	NULL
go-	NULL
go	NULL
>	NULL
4	NULL
$	NULL
o	NULL
do-	NULL
$	NULL
o	NULL
$	NULL
o	NULL
o	NULL
$	NULL
o-	NULL
$	NULL
o	NULL
-o	NULL
o	NULL
$	NULL
o	NULL
MAD	NULL
-	NULL
3	NULL
:	NULL
Control	NULL
:	NULL
tug	NULL
be	NULL
begs	NULL
U	NULL
‘	NULL
ﬁ	NULL
1	NULL
~	NULL
»	NULL
3	NULL
4	NULL
010-1112	NULL
13	NULL
14	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
recombinant	NULL
MAD-3	NULL
on	NULL
DNA	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
.	NULL

MAD-3	NULL
protein	NULL
expressed	NULL
as	NULL
a	NULL
fusion	NULL
protein	NULL
with	NULL
GST	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
or	NULL
a	NULL
GST	NULL
control	NULL
was	NULL
incubated	NULL
under	NULL
standard	NULL
EMSA	NULL
conditions	NULL
with	NULL
recombinant	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
p50	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
heterodimeric	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
/	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
,	NULL
recombinant	NULL
Spl	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
,	NULL
or	NULL
alone	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
3	NULL
versus	NULL
4	NULL
and	NULL
7	NULL
versus	NULL
8	NULL
)	NULL
.	NULL

When	NULL
GST-MAD-3	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
GST	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
either	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
or	NULL
NFKB1l	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
heterodimers	NULL
,	NULL
both	NULL
DNA-binding	NULL
activities	NULL
were	NULL
strongly	NULL
inhibited	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
5	NULL
versus	NULL
6	NULL
and	NULL
9	NULL
versus	NULL
10	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
neither	NULL
NFKB1	NULL
nor	NULL
NFKB2	NULL
affected	NULL
the	NULL
ability	NULL
of	NULL
MAD-3	NULL
to	NULL
interact	NULL
with	NULL
its	NULL
target	NULL
sequence	NULL
on	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
MAD-3	NULL
to	NULL
p49/	NULL
p65	NULL
or	NULL
p50/p65	NULL
heterodimers	NULL
,	NULL
while	NULL
inhibiting	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
heterodimeric	NULL
complex	NULL
,	NULL
also	NULL
stimulated	NULL
the	NULL
appearance	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
identical	NULL
in	NULL
mobility	NULL
to	NULL
the	NULL
respective	NULL
homodimer	NULL
,	NULL
again	NULL
suggesting	NULL
that	NULL
MAD-3	NULL
can	NULL
interact	NULL
directly	NULL
with	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
to	NULL
enhance	NULL
their	NULL
DNA-binding	NULL
properties	NULL
.	NULL

MAD-3	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
Spl	NULL
protein	NULL
to	NULL
its	NULL
cognate	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
these	NULL
inhibitory	NULL
and	NULL
stimulatory	NULL
effects	NULL
were	NULL
specific	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
by	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/RelA	NULL
(	NULL
p65	NULL
)	NULL
in	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
is	NULL
inhibited	NULL
by	NULL
MAD-3	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
transcriptional	NULL
activation	NULL
by	NULL
p49/p65	NULL
heterodimers	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
MAD-3	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
,	NULL
expression	NULL
vectors	NULL
encoding	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
and	NULL
MAD-3	NULL
were	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
T-lymphoma	NULL
cells	NULL
together	NULL
with	NULL
reporter	NULL
plasmids	NULL
containing	NULL
the	NULL
HIV	NULL
enhancer	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

Cotransfection	NULL
of	NULL
equal	NULL
amounts	NULL
of	NULL
p49	NULL
and	NULL
p65	NULL
plasmids	NULL
stimulated	NULL
transcription	NULL
mediated	NULL
through	NULL
the	NULL
HIV	NULL
LTR	NULL
approximately	NULL
13-fold	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
reports	NULL
,	NULL
this	NULL
transactivation	NULL
was	NULL
more	NULL
potent	NULL
with	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
than	NULL
with	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
expression	NULL
vectors	NULL
(	NULL
38	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Co	NULL
TRANSCRIPTIONAL	NULL
REGULATION	NULL
BY	NULL
NFKB2	NULL
AND	NULL
IkB-a	NULL
_	NULL
1319	NULL
transfection	NULL
of	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
MAD-3	NULL
almost	NULL
completely	NULL
inhibited	NULL
the	NULL
stimulation	NULL
observed	NULL
with	NULL
both	NULL
p49/p65	NULL
and	NULL
p50/p65	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
also	NULL
seen	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
bearing	NULL
the	NULL
heterologous	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
containing	NULL
multiple	NULL
kB	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MAD-3	NULL
had	NULL
no	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
kB-indepen-dent	NULL
transcription	NULL
stimulation	NULL
of	NULL
HIV	NULL
by	NULL
the	NULL
cytomegalovirus	NULL
immediate-early	NULL
gene	NULL
product	NULL
and	NULL
did	NULL
not	NULL
significantly	NULL
inhibit	NULL
CAT	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
RSV	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
effect	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
dose-respon-sive	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
MAD-3	NULL
exerts	NULL
its	NULL
inhibitory	NULL
effect	NULL
specifically	NULL
through	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
most	NULL
likely	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
examined	NULL
the	NULL
biochemical	NULL
basis	NULL
for	NULL
NFKB2	NULL
binding	NULL
to	NULL
kB	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
dimerize	NULL
and	NULL
interact	NULL
functionally	NULL
with	NULL
p65	NULL
and	NULL
MAD-3	NULL
.	NULL

We	NULL
find	NULL
that	NULL
the	NULL
affinities	NULL
and	NULL
specificities	NULL
of	NULL
DNA	NULL
binding	NULL
by	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
pS50	NULL
)	NULL
differ	NULL
considerably	NULL
.	NULL

Notably	NULL
,	NULL
binding	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReiA	NULL
(	NULL
p65	NULL
)	NULL
to	NULL
«	NULL
B	NULL
shows	NULL
more	NULL
than	NULL
fivefold-greater	NULL
affinity	NULL
than	NULL
does	NULL
binding	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
,	NULL
and	NULL
this	NULL
heterodimer	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
heterodimers	NULL
of	NULL
NF-KB	NULL
,	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
/RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
MAD-3	NULL
IxB	NULL
,	NULL
but	NULL
neither	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
nor	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
binding	NULL
was	NULL
inhibited	NULL
by	NULL
MAD-3	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
documents	NULL
that	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
RelA	NULL
{	NULL
(	NULL
p65	NULL
)	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
stimulate	NULL
HIV	NULL
transcription	NULL
.	NULL

Previous	NULL
studies	NULL
had	NULL
shown	NULL
that	NULL
overexpression	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
.	NULL

and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
stimulated	NULL
«	NULL
B-dependent	NULL
reporter	NULL
gene	NULL
transcription	NULL
in	NULL
transfected	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
possibility	NULL
remained	NULL
that	NULL
this	NULL
effect	NULL
was	NULL
indirect	NULL
,	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
due	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
a	NULL
cascade	NULL
of	NULL
stimulatory	NULL
events	NULL
or	NULL
an	NULL
association	NULL
with	NULL
endogenous	NULL
cellular	NULL
factors	NULL
)	NULL
.	NULL

The	NULL
data	NULL
reported	NULL
here	NULL
suggest	NULL
that	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/RelA	NULL
(	NULL
p65	NULL
)	NULL
exerts	NULL
a	NULL
direct	NULL
stimulatory	NULL
effect	NULL
on	NULL
transcriptional	NULL
initiation	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
homodimeric	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
protein	NULL
may	NULL
stimulate	NULL
«	NULL
B-dependent	NULL
transcription	NULL
independently	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
11	NULL
,	NULL
24	NULL
)	NULL
;	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
data	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
this	NULL
is	NULL
not	NULL
the	NULL
case	NULL
for	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
,	NULL
since	NULL
transcription	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
was	NULL
not	NULL
significantly	NULL
stimulated	NULL
by	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
weak	NULL
affinity	NULL
of	NULL
homodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
for	NULL
«	NULL
kB	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
relative	NULL
to	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
its	NULL
site	NULL
specificity	NULL
,	NULL
highlight	NULL
significant	NULL
differences	NULL
between	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
recombinant	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
for	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
(	NULL
K	NULL
,	NULL
,	NULL
=	NULL
69.1	NULL
pM	NULL
)	NULL
is	NULL
17.7	NULL
times	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
(	NULL
K	NULL
,	NULL
,	NULL
=	NULL
3.9	NULL
pM	NULL
)	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

The	NULL
binding	NULL
K	NULL
,	NULL
,	NULL
of	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
for	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
compares	NULL
very	NULL
favorably	NULL
with	NULL
results	NULL
of	NULL
a	NULL
previous	NULL
report	NULL
(	NULL
11	NULL
;	NULL
3.9	NULL
pM	NULL
versus	NULL
6.7	NULL
pM	NULL
)	NULL
which	NULL
used	NULL
nearly	NULL
identical	NULL
experimental	NULL
conditions	NULL
.	NULL

While	NULL
the	NULL
affinities	NULL
of	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
for	NULL
the	NULL
H-2	NULL
«	NULL
B	NULL
and	NULL
HIV	NULL
xB	NULL
sites	NULL
are	NULL
very	NULL
similar	NULL
(	NULL
10a	NULL
,	NULL
11	NULL
)	NULL
,	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
has	NULL
a	NULL
four-	NULL
to	NULL
fivefold-higher	NULL
affinity	NULL
for	NULL
the	NULL
H-2	NULL
site	NULL
(	NULL
K	NULL
,	NULL
,	NULL
=	NULL
15.7	NULL
pM	NULL
)	NULL
than	NULL
for	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
(	NULL
K	NULL
,	NULL
,	NULL
=	NULL
69.1	NULL
pM	NULL
)	NULL
.	NULL

Heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
site	NULL
with	NULL
~6-fold-higher	NULL
affinity	NULL
(	NULL
K	NULL
,	NULL
,	NULL
=	NULL
11.8	NULL
pM	NULL
)	NULL
than	NULL
does	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
alone	NULL
.	NULL

This	NULL
difference	NULL
in	NULL
affinity	NULL
is	NULL
not	NULL
observed	NULL
with	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
whose	NULL
affinities	NULL
for	NULL
the	NULL
HIV	NULL
element	NULL
as	NULL
either	NULL
a	NULL
homodimer	NULL
or	NULL
a	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
/	NULL
(	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
heterodimer	NULL
(	NULL
6.7	NULL
pM	NULL
versus	NULL
5.7	NULL
pm	NULL
[	NULL
11	NULL
]	NULL
)	NULL
are	NULL
very	NULL
similar	NULL
(	NULL
10a	NULL
,	NULL
24	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
relatively	NULL
lower	NULL
1320	NULL
DUCKEIT	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
B	NULL
%	NULL
Conversion	NULL
%	NULL
Conversion	NULL
MAD~®	NULL
:	NULL
<	NULL
4	NULL
-+	NULL
-+	NULL
t	NULL
+	NULL
1	NULL
+	NULL
1	NULL
+	NULL
w-	NULL
Q	NULL
u	NULL
)	NULL
%	NULL
%	NULL
$	NULL
§	NULL
%	NULL
a	NULL
be	NULL
a	NULL
&	NULL
o	NULL
t	NULL
i	NULL
)	NULL
o	NULL
.	NULL

+s	NULL
Co-transfected	NULL
Plasmid	NULL
Co-transfected	NULL
Plasmid	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

C	NULL
124	NULL
RSV-CAT	NULL
10-7	NULL
’	NULL
v	NULL
s+	NULL
C	NULL
.9	NULL
©	NULL
z	NULL
4	NULL
5	NULL
8	NULL
Ed	NULL
4-21	NULL
HIV-CAT	NULL
Co-transfected	NULL
MAD-3	NULL
(	NULL
ug	NULL
)	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Evidence	NULL
that	NULL
stimulation	NULL
of	NULL
«	NULL
B-dependent	NULL
CAT	NULL
activity	NULL
by	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
expression	NULL
vectors	NULL
is	NULL
blocked	NULL
by	NULL
coexpression	NULL
of	NULL
MAD-3	NULL
in	NULL
vivo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
g	NULL
of	NULL
HIV-CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
0.2	NULL
ug	NULL
of	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
,	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
or	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
as	NULL
indicated	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
RSV-MAD-3	NULL
expression	NULL
vector	NULL
as	NULL
indicated	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
,	NULL
or	NULL
0.5	NULL
ug	NULL
of	NULL
an	NULL
RSV-B-galactosidase	NULL
control	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
;	NULL
CAT	NULL
activity	NULL
is	NULL
shown	NULL
as	NULL
percent	NULL
conversion	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
MAD-3	NULL
on	NULL
«	NULL
B-independent	NULL
CAT	NULL
transcription	NULL
.	NULL

A	NULL
0.5-ug	NULL
sample	NULL
of	NULL
MAD-3	NULL
or	NULL
a	NULL
promoter	NULL
control	NULL
was	NULL
cotransfected	NULL
with	NULL
2	NULL
pg	NULL
of	NULL
RSV-CAT	NULL
(	NULL
15	NULL
)	NULL
or	NULL
5	NULL
ug	NULL
of	NULL
a	NULL
«	NULL
B-mutated	NULL
HIV-CAT	NULL
reporter	NULL
plasmid	NULL
with	NULL
a	NULL
plasmid	NULL
expressing	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
immediate-early	NULL
gene	NULL
(	NULL
12	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Dose-response	NULL
inhibition	NULL
of	NULL
p49/p65-mediated	NULL
activation	NULL
by	NULL
MAD-3	NULL
.	NULL

NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
vectors	NULL
(	NULL
0.2	NULL
mg	NULL
)	NULL
with	NULL
HIV-CAT	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
or	NULL
RSV-CAT	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
MAD-3	NULL
or	NULL
RSV	NULL
promoter	NULL
control	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

All	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

affinity	NULL
of	NULL
the	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
complex	NULL
for	NULL
«	NULL
kB	NULL
may	NULL
explain	NULL
why	NULL
NFKB2	NULL
was	NULL
not	NULL
identified	NULL
initially	NULL
by	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
from	NULL
affinity-purified	NULL
NF-kB	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
subunit	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
3'°	NULL
(	NULL
CTTTCC	NULL
)	NULL
half-site	NULL
of	NULL
the	NULL
HIV	NULL
«	NULL
B	NULL
sequence	NULL
,	NULL
although	NULL
with	NULL
low	NULL
affinity	NULL
(	NULL
45	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
likely	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
is	NULL
stabilized	NULL
by	NULL
the	NULL
affinity	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
for	NULL
this	NULL
half-site	NULL
.	NULL

Although	NULL
the	NULL
affinity	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
for	NULL
«	NULL
kB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
considerably	NULL
weaker	NULL
than	NULL
that	NULL
of	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
nonetheless	NULL
stimulates	NULL
the	NULL
<	NULL
B-directed	NULL
transcription	NULL
of	NULL
several	NULL
genes	NULL
more	NULL
potently	NULL
than	NULL
does	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
when	NULL
associated	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
affinity	NULL
of	NULL
binding	NULL
to	NULL
DNA	NULL
is	NULL
not	NULL
the	NULL
only	NULL
determinant	NULL
of	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
for	NULL
the	NULL
HIV	NULL
enhancer	NULL
.	NULL

Despite	NULL
their	NULL
differences	NULL
in	NULL
DNA-binding	NULL
affinity	NULL
,	NULL
the	NULL
interactions	NULL
of	NULL
both	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
MAD-3	NULL
were	NULL
indistinguishable	NULL
.	NULL

In	NULL
DNA-binding	NULL
experiments	NULL
,	NULL
MAD-3	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
any	NULL
complex	NULL
which	NULL
contained	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
regardless	NULL
of	NULL
its	NULL
associated	NULL
subunit	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
homodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
was	NULL
stimulated	NULL
by	NULL
MAD-3	NULL
.	NULL

Although	NULL
MAD-3	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
heterodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/Rel	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
to	NULL
DNA	NULL
,	NULL
in	NULL
the	NULL
same	NULL
reaction	NULL
it	NULL
was	NULL
found	NULL
to	NULL
stimulate	NULL
the	NULL
appearance	NULL
of	NULL
homodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

While	NULL
MAD-3	NULL
may	NULL
conceivably	NULL
exert	NULL
these	NULL
stimulatory	NULL
effects	NULL
by	NULL
disrupting	NULL
the	NULL
heterodimeric	NULL
complex	NULL
and	NULL
sequestering	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
allowing	NULL
newly	NULL
formed	NULL
homodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
or	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
to	NULL
bind	NULL
,	NULL
we	NULL
believe	NULL
it	NULL
more	NULL
likely	NULL
that	NULL
MAD-3	NULL
can	NULL
directly	NULL
stimulate	NULL
the	NULL
binding	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
since	NULL
the	NULL
same	NULL
effect	NULL
is	NULL
observed	NULL
with	NULL
homodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
.	NULL

We	NULL
postulate	NULL
that	NULL
our	NULL
preparations	NULL
of	NULL
heterodimeric	NULL
protein	NULL
contain	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
homodimeric	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
or	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
whose	NULL
DNA-binding	NULL
properties	NULL
are	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
MAD-3	NULL
.	NULL

MAD-3	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
unrelated	NULL
factor	NULL
,	NULL
Spl	NULL
,	NULL
for	NULL
its	NULL
cognate	NULL
site	NULL
,	NULL
and	NULL
MAD-3	NULL
itself	NULL
possessed	NULL
no	NULL
detectable	NULL
DNA-binding	NULL
properties	NULL
.	NULL

This	NULL
observation	NULL
suggests	NULL
that	NULL
MAD-3	NULL
is	NULL
capable	NULL
of	NULL
interacting	NULL
specifically	NULL
with	NULL
Rel-related	NULL
proteins	NULL
without	NULL
necessarily	NULL
inhibiting	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

This	NULL
possibility	NULL
is	NULL
supported	NULL
by	NULL
two	NULL
earlier	NULL
reports	NULL
.	NULL

The	NULL
first	NULL
of	NULL
these	NULL
(	NULL
25	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
ankyrin	NULL
repeat-containing	NULL
protein	NULL
,	NULL
GABP-B	NULL
,	NULL
can	NULL
enhance	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
Ets-related	NULL
protein	NULL
,	NULL
GABP-	NULL
«	NULL
,	NULL
and	NULL
the	NULL
second	NULL
(	NULL
21	NULL
)	NULL
reported	NULL
that	NULL
antibodies	NULL
raised	NULL
against	NULL
IxB	NULL
could	NULL
recognize	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

However	NULL
,	NULL
since	NULL
overexpression	NULL
of	NULL
MAD-3	NULL
inhibited	NULL
«	NULL
B-dependent	NULL
transactivation	NULL
in	NULL
all	NULL
cases	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
MAD-3	NULL
on	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
binding	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
its	NULL
functional	NULL
properties	NULL
,	NULL
and	NULL
so	NULL
the	NULL
biological	NULL
significance	NULL
of	NULL
this	NULL
unexpected	NULL
effect	NULL
is	NULL
unclear	NULL
.	NULL

MAD-3	NULL
also	NULL
prevented	NULL
functional	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
MAD-3	NULL
,	NULL
overexpression	NULL
of	NULL
either	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
,	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
or	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
slightly	NULL
stimulated	NULL
HIV-CAT	NULL
through	NULL
the	NULL
«	NULL
B	NULL
site	NULL
,	NULL
and	NULL
we	NULL
have	NULL
previously	NULL
postulated	NULL
that	NULL
this	NULL
low-level	NULL
stimulation	NULL
may	NULL
be	NULL
due	NULL
to	NULL
association	NULL
with	NULL
endogenous	NULL
NF-kB	NULL
subunits	NULL
(	NULL
38	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
or	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
however	NULL
,	NULL
provided	NULL
greater	NULL
stimulation	NULL
,	NULL
particularly	NULL
with	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
a	NULL
MAD-3	NULL
expression	NULL
vector	NULL
inhibited	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
/ReIA	NULL
(	NULL
p65	NULL
)	NULL
or	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
/	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
stimulation	NULL
by	NULL
80	NULL
to	NULL
90	NULL
%	NULL
in	NULL
all	NULL
cases	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
protein	NULL
encoded	NULL
by	NULL
NFKB2	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
.	NULL

The	NULL
role	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
in	NULL
the	NULL
control	NULL
of	NULL
other	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
is	NULL
not	NULL
yet	NULL
fully	NULL
understood	NULL
.	NULL

The	NULL
recent	NULL
identification	NULL
of	NULL
NFKB2	NULL
in	NULL
association	NULL
with	NULL
translocation	NULL
in	NULL
a	NULL
B-cell	NULL
lymphoma	NULL
suggests	NULL
that	NULL
NFKB2	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
cycle	NULL
regulation	NULL
or	NULL
oncogenesis	NULL
.	NULL

Despite	NULL
the	NULL
considerable	NULL
structural	NULL
similarity	NULL
of	NULL
NFKB1	NULL
and	NULL
NFKB2	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
show	NULL
that	NULL
these	NULL
gene	NULL
products	NULL
have	NULL
distinct	NULL
biochemical	NULL
properties	NULL
.	NULL

These	NULL
biochemical	NULL
differences	NULL
provide	NULL
a	NULL
molecular	NULL
basis	NULL
to	NULL
explain	NULL
functional	NULL
differences	NULL
between	NULL
NFKB1	NULL
and	NULL
NFKB2	NULL
.	NULL

These	NULL
results	NULL
also	NULL
demonstrate	NULL
that	NULL
despite	NULL
their	NULL
similarity	NULL
,	NULL
these	NULL
DNA-binding	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
differ	NULL
significantly	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
stimulate	NULL
transcription	NULL
.	NULL

The	NULL
interactions	NULL
between	NULL
alternative	NULL
NF-kB	NULL
complexes	NULL
and	NULL
other	NULL
cellular	NULL
transcription	NULL
factors	NULL
would	NULL
thus	NULL
provide	NULL
a	NULL
mechanism	NULL
to	NULL
selectively	NULL
regulate	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
,	NULL
and	NULL
they	NULL
suggest	NULL
that	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
difference	NULL
between	NULL
the	NULL
ability	NULL
of	NULL
NFKB2	NULL
(	NULL
p49	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
p50	NULL
)	NULL
to	NULL
activate	NULL
transcription	NULL
is	NULL
independent	NULL
of	NULL
DNA-binding	NULL
affinity	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Donna	NULL
Gschwend	NULL
for	NULL
secretarial	NULL
assistance	NULL
;	NULL
Kwanyee	NULL
Leung	NULL
for	NULL
technical	NULL
support	NULL
;	NULL
E.	NULL
Blair	NULL
for	NULL
helpful	NULL
discussions	NULL
;	NULL
G.	NULL
Nolan	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
recombinant	NULL
p65	NULL
protein	NULL
;	NULL
R.	NULL
Roeder	NULL
for	NULL
kindly	NULL
providing	NULL
plasmid	NULL
p	NULL
(	NULL
C	NULL
;	NULL
AT	NULL
)	NULL
,	NULL
;	NULL
U.	NULL
Schibler	NULL
for	NULL
kindly	NULL
providing	NULL
plasmid	NULL
pML200	NULL
;	NULL
and	NULL
R.	NULL
Bandziulis	NULL
and	NULL
Promega	NULL
Corp.	NULL
for	NULL
providing	NULL
reagents	NULL
and	NULL
assisting	NULL
with	NULL
protein	NULL
purification	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
British	NULL
Medical	NULL
Research	NULL
Council	NULL
's	NULL
AIDS	NULL
Directed	NULL
Programme	NULL
(	NULL
C.S.D	NULL
.	NULL
)	NULL

,	NULL
Deutsche	NULL
For-schungsgemeinschaft	NULL
fellowship	NULL
740/2-1	NULL
(	NULL
R.M.S	NULL
.	NULL
)	NULL

,	NULL
grants	NULL
AI26865	NULL
and	NULL
A1I29179	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
G.J.N	NULL
.	NULL
)	NULL

,	NULL
grants	NULL
CA21773	NULL
(	NULL
E.-S.H	NULL
.	NULL
)	NULL

and	NULL
CA52515	NULL
(	NULL
A.S.B	NULL
.	NULL
)	NULL

from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Damon	NULL
Runyon-Walter	NULL
Winchell	NULL
Cancer	NULL
Research	NULL
Fund	NULL
DRG-1097	NULL
(	NULL
T.F.K	NULL
.	NULL
)	NULL

,	NULL
American	NULL
Cancer	NULL
Society	NULL
grant	NULL
JFRA-309	NULL
(	NULL
A.S.B	NULL
.	NULL
)	NULL

,	NULL
March	NULL
of	NULL
Dimes	NULL
Basil	NULL
O'Connor	NULL
Award	NULL
(	NULL
A.S.B	NULL
.	NULL
)	NULL

,	NULL
and	NULL
an	NULL
RJR-Nabisco	NULL
Scholar	NULL
Award	NULL
in	NULL
Immunology	NULL
(	NULL
A.S.B	NULL
.	NULL
)	NULL

C.S.D	NULL
.	NULL

is	NULL
also	NULL
affiliated	NULL
with	NULL
the	NULL
Department	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Sciences	NULL
,	NULL
St.	NULL
George	NULL
's	NULL
Hospital	NULL
Medical	NULL
School	NULL
,	NULL
London	NULL
,	NULL
England	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Bio-phys	NULL
.	NULL

Acta	NULL
1072:63-80	NULL
.	NULL

2	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

I	NULL
kappa	NULL
B	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242	NULL
:	NULL
540-546	NULL
.	NULL

3	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

4	NULL
.	NULL

Baeuverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-KB	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

5	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1987	NULL
.	NULL

Binding	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
to	NULL
a	NULL
regulatory	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
mouse	NULL
H-2K	NULL
``	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:305-313	NULL
.	NULL

TRANSCRIPTIONAL	NULL
REGULATION	NULL
BY	NULL
NFKB2	NULL
AND	NULL
IkB-a	NULL
-	NULL
1321	NULL
6	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
same	NULL
inducible	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
regulates	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
interleukin-2	NULL
receptor-alpha	NULL
gene	NULL
and	NULL
type	NULL
1	NULL
HIV	NULL
.	NULL

Cell	NULL
§3:827-836	NULL
.	NULL

7	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50/p105-NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
xB	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685-695	NULL
.	NULL

8	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
«	NULL
B	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80	NULL
.	NULL

9	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Mittereder	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
human	NULL
rel	NULL
proto-oncogene	NULL
cDNA	NULL
containing	NULL
an	NULL
Alu	NULL
fragment	NULL
as	NULL
a	NULL
potential	NULL
coding	NULL
exon	NULL
.	NULL

Oncogene	NULL
4:935-942	NULL
.	NULL

10	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
D.	NULL
L.	NULL
Simmons	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Rel-associated	NULL
pp40	NULL
:	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Science	NULL
253:1268-1271	NULL
.	NULL

10a.Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

11	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

Independent	NULL
modes	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:775-787	NULL
.	NULL

12	NULL
.	NULL

Ghazal	NULL
,	NULL
P.	NULL
,	NULL
J	NULL
.	NULL

Young	NULL
,	NULL
E.	NULL
Giulietti	NULL
,	NULL
C.	NULL
DeMattei	NULL
,	NULL
J.	NULL
Garcia	NULL
,	NULL
R.	NULL
Gaynor	NULL
,	NULL
R.	NULL
M.	NULL
Stenberg	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
discrete	NULL
cis	NULL
element	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
mediates	NULL
synergistic	NULL
frans-activation	NULL
by	NULL
cytomegalovirus	NULL
immediate-early	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6735-6742	NULL
.	NULL

13	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
:	NULL
678-682	NULL
.	NULL

14	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-kB	NULL
:	NULL
homology	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

15	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
G.	NULL
T.	NULL
Merlino	NULL
,	NULL
M.	NULL
C.	NULL
Willingham	NULL
,	NULL
I.	NULL
Pastan	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

The	NULL
Rouse	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
is	NULL
a	NULL
strong	NULL
promoter	NULL
when	NULL
introduced	NULL
into	NULL
a	NULL
variety	NULL
of	NULL
eukaryotic	NULL
cells	NULL
by	NULL
DNA-mediated	NULL
transfection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:6777-6781	NULL
.	NULL

16	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

17	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
A.	NULL
Kakizuka	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1992	NULL
.	NULL

I	NULL
kappa	NULL
B	NULL
gamma	NULL
,	NULL
a	NULL
70	NULL
kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110	NULL
NF-kappa	NULL
B	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
I	NULL
kappa	NULL
B	NULL
family	NULL
.	NULL

Cell	NULL
68:1109-1120	NULL
.	NULL

18	NULL
.	NULL

Israel	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Kimura	NULL
,	NULL
M.	NULL
Kieran	NULL
,	NULL
O.	NULL
Yano	NULL
,	NULL
J.	NULL
Kanellopoulos	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
and	NULL
P.	NULL
Kourilsky	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
common	NULL
positive	NULL
transacting	NULL
factor	NULL
binds	NULL
to	NULL
enhancer	NULL
sequences	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
mouse	NULL
H-2	NULL
and	NULL
b-2	NULL
microglobulin	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:2653-2657	NULL
.	NULL

19	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Affinity	NULL
purification	NULL
of	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:5889-5893	NULL
.	NULL

20	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Scheidereit	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
human	NULL
immunoglobulin-enhancer-binding	NULL
protein	NULL
(	NULL
NF-kappa	NULL
B	NULL
)	NULL
that	NULL
activates	NULL
transcription	NULL
from	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:4700-4704	NULL
.	NULL

21	NULL
.	NULL

Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
N.	NULL
Davis	NULL
,	NULL
E.	NULL
Link	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
,	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
rel-associated	NULL
pp40	NULL
protein	NULL
prevents	NULL
DNA	NULL
binding	NULL
of	NULL
rel	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
relationship	NULL
with	NULL
IxBB	NULL
and	NULL
regulation	NULL
by	NULL
phosphorylation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1464-1476	NULL
.	NULL

22	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

1322	NULL
DUCKETT	NULL
ET	NULL
AL	NULL
.	NULL

22a.Kowalik	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
1989	NULL
.	NULL

The	NULL
scanning	NULL
model	NULL
for	NULL
translation	NULL
:	NULL
an	NULL
update	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

108:229-241	NULL
.	NULL

Kretzschmar	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Meisterernst	NULL
,	NULL
C.	NULL
Scheidereit	NULL
,	NULL
G.	NULL
Li	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:761-774	NULL
.	NULL

LaMarco	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
C.	NULL
Thompson	NULL
,	NULL
B.	NULL
P.	NULL
Byers	NULL
,	NULL
E.	NULL
M.	NULL
Waiton	NULL
,	NULL
and	NULL
S	NULL
$	NULL
.	NULL

L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
Ets-	NULL
and	NULL
Notch-related	NULL
subunits	NULL
in	NULL
GA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
253:789-792	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue	NULL
specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
C.-M	NULL
.	NULL

Fan	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
NF-kB	NULL
in	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
reveals	NULL
its	NULL
role	NULL
as	NULL
widely	NULL
inducible	NULL
mediator	NULL
of	NULL
signal	NULL
transduc-tion	NULL
.	NULL

Cell	NULL
57:287-294	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Link	NULL
,	NULL
E.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
U.	NULL
Zabel	NULL
,	NULL
I.	NULL
Verma	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuverle	NULL
.	NULL

1992	NULL
.	NULL

Purified	NULL
I	NULL
kappa	NULL
B-beta	NULL
is	NULL
inactivated	NULL
upon	NULL
dephosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:239-246	NULL
.	NULL

Liou	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
NF-kappa	NULL
B	NULL
p50	NULL
precursor	NULL
,	NULL
p105	NULL
,	NULL
contains	NULL
an	NULL
internal	NULL
I	NULL
kappa	NULL
B-like	NULL
inhibitor	NULL
that	NULL
preferentially	NULL
inhibits	NULL
p50	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3003-3009	NULL
.	NULL

30a.Liptay	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
P.	NULL
Meltzer	NULL
,	NULL
M.	NULL
R.	NULL
Altherr	NULL
,	NULL
J.	NULL
D.	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

McPherson	NULL
,	NULL
J.	NULL
J.	NULL
Wasmuth	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Related	NULL
subunits	NULL
of	NULL
NF-kB	NULL
map	NULL
to	NULL
two	NULL
distinct	NULL
loci	NULL
associated	NULL
with	NULL
translocations	NULL
in	NULL
leukemia	NULL
,	NULL
NFKB1l	NULL
and	NULL
NFKB2	NULL
.	NULL

Genomics	NULL
13:287-292	NULL
.	NULL

Maire	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Wuarin	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
role	NULL
of	NULL
cis-acting	NULL
promoter	NULL
elements	NULL
in	NULL
tissue-specific	NULL
albumin	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
244:343-346	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
N.	NULL
Hatada	NULL
,	NULL
H.-P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Rothlisberger	NULL
,	NULL
H.-W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
Van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
kB	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
C.-C.	NULL
Chang	NULL
,	NULL
L.	NULL
Lombardi	NULL
,	NULL
M.	NULL
Salina	NULL
,	NULL
P.	NULL
Corradini	NULL
,	NULL
A.	NULL
T.	NULL
Maiolo	NULL
,	NULL
R.	NULL
S.	NULL
Chaganti	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1991	NULL
.	NULL

B	NULL
cell	NULL
lymphoma-associated	NULL
chromosomal	NULL
translocation	NULL
involves	NULL
candidate	NULL
oncogene	NULL
lyt-10	NULL
,	NULL
homologous	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
pS0	NULL
.	NULL

Cell	NULL
67	NULL
:	NULL
1075-1087	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
inhibitory	NULL
ankyrin	NULL
and	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

38a	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

Mor	NULL
.	NULL

CE	NULL
.	NULL

Bor	NULL
.	NULL

activator	NULL
Rel	NULL
proteins	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2:211-220	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin-1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
$	NULL
9:1529-1533	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Poteat	NULL
,	NULL
T.	NULL
H.	NULL
Tan	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
W.	NULL
Haseltine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1988	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-1	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89-91.	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
R.	NULL
Narayanan	NULL
,	NULL
J.	NULL
F.	NULL
Klement	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
spliced	NULL
deriv-ative	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:444-454	NULL
.	NULL

Sawadogo	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1985	NULL
.	NULL

Factors	NULL
involved	NULL
in	NULL
specific	NULL
transcription	NULL
by	NULL
human	NULL
RNA	NULL
polymerase	NULL
II	NULL
:	NULL
analysis	NULL
by	NULL
a	NULL
rapid	NULL
and	NULL
quantitative	NULL
in	NULL
vitro	NULL
assay	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:4394-4398	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736.	NULL
.	NULL

Steward	NULL
,	NULL
R.	NULL
1987	NULL
.	NULL

Dorsal	NULL
,	NULL
an	NULL
embryonic	NULL
polarity	NULL
gene	NULL
in	NULL
Dros-	NULL
ophila	NULL
,	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
vertebrate	NULL
proto-oncogene	NULL
,	NULL
c-rel	NULL
.	NULL

Science	NULL
238:692-694	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IxB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1975-1984	NULL
.	NULL

Yano	NULL
,	NULL
O.	NULL
,	NULL
J.	NULL
Kanellopoulos	NULL
,	NULL
M.	NULL
Kieran	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
A.	NULL
Israet	NULL
,	NULL
and	NULL
P.	NULL
Kourilsky	NULL
.	NULL

1987	NULL
.	NULL

Purification	NULL
of	NULL
KBF1l	NULL
,	NULL
a	NULL
common	NULL
factor	NULL
binding	NULL
to	NULL
both	NULL
H-2	NULL
and	NULL
b2-microglobulin	NULL
enhancers	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:3317-3324	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1990	NULL
.	NULL

Purified	NULL
human	NULL
I	NULL
kappa	NULL
B	NULL
can	NULL
rapidly	NULL
dissociate	NULL
the	NULL
complex	NULL
of	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
with	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

Cell	NULL
61:255-265	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
of	NULL
purified	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:252-260	NULL
.	NULL

